NCT06983431 DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT
| NCT ID | NCT06983431 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Slovak Academy of Sciences |
| Condition | Pre-obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 320 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 320 participants in total. It began in 2025-05-05 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The principal objective of the project is: * to bring together academic and business research organisations in a joint partnership integrating technological and social innovation, * in order to develop proof-of-concept of a scalable and cost effective personalised digital health program for (pre)obesity patients, * by integrating, in an ethical manner, adaptive AI components aimed at personalisation of the program as well as its cost management, * with the ultimate objective to support sustained behavioural change leading to adoption and internalisation of healthy lifestyle choices.
Eligibility Criteria
Inclusion Criteria: * obesity (BMI 27-42 kg/m²) * capacity and willingness to use smartphone * capacity and willingness to use wearables * readiness to change (validated questionaire) Exclusion Criteria: * diseases that prevent participation in the program, or insufficiently controlled diseases, or terminal-stage illnesses * excessive alcohol consumption or a history of other addictions * patients currently participating in a weight-loss program (commercial, medically supervised, or a research study) * patients using anti-obesity medications who are in the dosage adjustment phase within the last four weeks * patients who are not mentally, physically, or technologically capable of participating * patients who are unable to provide informed consent * patients not adhering to the study protocol
Contact & Investigator
Jozef Ukropec, PhD, DSc
PRINCIPAL INVESTIGATOR
Biomedical Research Center Slovak Acad Sci
Frequently Asked Questions
Who can join the NCT06983431 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Pre-obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06983431 currently recruiting?
Yes, NCT06983431 is actively recruiting participants. Contact the research team at barbara.ukropcova@savba.sk for enrollment information.
Where is the NCT06983431 trial being conducted?
This trial is being conducted at Bratislava, Slovakia.
Who is sponsoring the NCT06983431 clinical trial?
NCT06983431 is sponsored by Slovak Academy of Sciences. The principal investigator is Jozef Ukropec, PhD, DSc at Biomedical Research Center Slovak Acad Sci. The trial plans to enroll 320 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.